IBS patients showed reduced neuropeptide S and neuropeptide Y levels alongside increased mast cell activity and PAR-2 expression, connecting psychological stress to gut symptoms through a neuropeptide-mast cell axis.
NPS and NPY downregulated in IBSWhile mast cells and PAR-2 were upregulated, suggesting an interconnected pathway driving symptoms
What the researchers found
IBS-D patients showed downregulated NPS, NPY, and NPY2R alongside increased mast cell activation and PAR-2 expression, suggesting mast cell-driven neuropeptide changes link gut inflammation to psychological symptoms.
Why it matters
IBS affects up to 15% of the global population. Understanding the molecular connection between stress, neuropeptides, and gut symptoms could lead to targeted therapies addressing both the psychological and gastrointestinal components simultaneously.
The numbers in context
28 IBS-D vs 8 controls; MC and tryptase-positive MC increased; PAR-2 up; NPS, NPY, NPY2R down; SDS and SAS scores higher in IBS
How the study worked
Case-control study: 28 IBS-D patients vs. 8 healthy controls. Colonoscopic biopsies analyzed by immunohistochemistry and Western blot. ELISA for NPS and NPY in plasma and tissue. SDS and SAS for psychological assessment.
Who was studied
28 diarrhea-predominant IBS patients (ages 20-64) and 8 healthy controls (ages 35-63)
What this study cannot tell us
Small sample size, especially controls (n=8). Cross-sectional design cannot establish causation. IBS-D subtype only — may not apply to constipation-predominant IBS. Correlation between indicators doesn't prove the proposed causal pathway.
How to read the evidence
Small case-control study with direct tissue analysis. Provides hypothesis-generating evidence but limited by small sample size and cross-sectional design.
When this study was published
Published in 2021, contributing to molecular understanding of the gut-brain axis in IBS.
The bigger picture
The gut-brain axis in IBS is well-recognized but poorly understood at the molecular level. This study provides evidence that neuropeptides serve as molecular bridges between psychological stress and gut dysfunction, with mast cells as key intermediaries — supporting the concept of treating IBS as a neuro-gastroenterological disorder.
Questions still open
- Could mast cell stabilizers improve both gut and psychological symptoms in IBS?
- Would NPY supplementation or receptor agonists be therapeutic for IBS?
- Does the same neuropeptide pattern exist in other IBS subtypes?
Common questions
How are stress and IBS connected at the molecular level?
Could treating mast cells help IBS symptoms?
Read the original research
Research on Correlation Between Psychological Factors, Mast Cells, and PAR-2 Signal Pathway in Irritable Bowel syndrome.
Journal of inflammation research, 14, 1427-1436
Citation
Chao, Guanqun; Wang, Zhaojun; Zhang, Shuo. (2021). Research on Correlation Between Psychological Factors, Mast Cells, and PAR-2 Signal Pathway in Irritable Bowel syndrome.. Journal of inflammation research, 14, 1427-1436. https://doi.org/10.2147/JIR.S300513